Liva Healthcare Attracts Top Medical Scientific Leaders to Global Advisory Board
04 Marzo 2021 - 01:00AM
Business Wire
A leading provider of scalable digital health
coaching in Europe, Liva Healthcare (“Liva”), launches new
Scientific Advisory Board. Liva has attracted some of Europe’s most
respected scientific leaders within chronic conditions and
behaviour change psychology to join its global Advisory Board. The
board will oversee the medical quality of the programmes and
conduct the latest scientific research into Liva’s behavioural
change model.
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20210303005646/en/
Liva Healthcare (Photo: Business
Wire)
Liva is a health tech company that improve the lives of people
at risk of, or living with, chronic conditions such as type 2
diabetes, obesity, and cardiovascular diseases by driving positive
behavioural change. Liva recently announced a new funding round of
EUR 24.5 million with the aim to expand its European operations.
The Liva programmes are used by leading players in public
healthcare, insurance and life science industries globally.
Through an app, Liva provides personal human coaching programmes
to help people manage their condition and develop healthier habits
that last. Liva’s combination of scalable health coaching focused
on personal human relationships, with an intuitive and
user-friendly interface, has proven to drive substantial clinical
outcomes, and is particularly effective among traditionally hard to
reach socio-economic groups.
Users on the programme living with obesity have an average
sustained weight loss of 6,8kg during the first 9 months, 85% of
users at high risk of developing type 2 diabetes reduce their HbA1c
levels in 6 months, and 44% of users living with type 2 diabetes
normalise their HbA1c level and achieve ‘control’ of their
condition after 12 months on the programme (HbA1c level gets below
48 mmol/mol (6,5%).
The Advisory Board will be chaired by Liva’s Chief Medical
Officer, MD, PhD, Carl J. Brandt, Postdoctoral researcher at the
Research Unit for General Practice, University of Southern
Denmark.
“We are proud to present a global Advisory Board of this
calibre. With this board, Liva has managed to attract some of
Europe’s top scientific leaders to oversee the medical and ethical
quality of the Liva programmes, give input on study scope and
design, and oversee the evidence-based nature of the Liva
programmes,” says Dr. Brandt. “We have gathered multiple
competences within our therapeutic and technological areas to guide
decision-making and ensure science and research is the foundation
for everything we do,” adds Dr. Brandt.
Joining Liva’s Advisory Board is Prof. Dr Lisette Van
Gemert-Pijnen, Chair of Persuasive Health Technology at university
of Twente, and Head of Centre for eHealth & Wellbeing
Research.
“In our research at university of Twente and the Centre for
eHealth & Wellbeing Research, we study how persuasive health
technology can be applied to increase self-management of long-term
chronic diseases, like diabetes,” says Prof. Gemert-Pijnen. “Liva
Healthcare has demonstrated impressive proven clinical outcomes in
chronic disease prevention and management, especially within
obesity, prediabetes and type 2 diabetes, and that is why I have
decided to join the Advisory Board.”
“I have been conducting research on the Dutch COVID-19 contact
tracing app: CoronaMelder, and COVID-19 has taught us the
importance of user-friendly, reliable and inclusive digital health
tools. Generally, there has been a shift in acceptance of remote
healthcare, and the need for credible digital solutions is now
greater than ever. Fortunately, the Liva programmes have
demonstrated how effective personalised, remote health solutions
can be, and I am delighted to take a seat in this highly competent
Advisory Board,” adds Prof. Gemert-Pijnen.
Additional Advisory Board members include:
- Prof. Timothy Skinner, Director of
University department of Rural Health at La Trobe University, and
Professor of Health Psychology at University of Copenhagen. Prof.
Skinner has been responsible for developing several diabetes
self-management support programmes, including DESMOND, the longest
standing NHS training course for people with type 2 diabetes.
- Prof. Thorsten Lewalter, Head of Department
of Cardiology, int. Klinikum München Süd, and Director of
Department of Cardiology, Peter Osypka Heart Center. Prof. Lewalter
is a renowned cardiology expert. He is co-editor of numerous
professional journals and is considered one of the founders of
modern therapy of cardiac arrhythmias.
- Stephanie Kaiser, Founder and Managing
Director of the digital health platform Heartbeat Labs. Kaiser has
more than 12 years’ experience in building and developing digital,
consumer-oriented products. Since 2018, Kaiser has been a member of
the Digital Council that advises the chancellor of Germany and the
German government on the important matter of digitalisation.
- Prof. Åke Sj�holm, Associate Professor of
Medicine at University of Gävle, Associate Professor at Karolinska
Institute, Professor of University of South Alabama, and Associate
Professor Diabetes at Region Gävleborg. Prof. Sj�holm is a
prominent Swedish diabetes expert and has been listed as a
noteworthy diabetes researcher by Marquis Who's Who.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210303005646/en/
Lewis Oakley +44 7767 887 035 lewis@milkandhoneypr.com Jonas
Damsgaard Jensen +45 42306013 jdj@livahealth.com